Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The study estimates the efficacy and safety of MK0476 and aminophylline intravenous administration in adult participants with acute asthma.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Aminophylline; Montelukast; Theophylline

Criteria

Inclusion Criteria:

• Adult participants with acute asthma attacks

Exclusion Criteria:

• Participant has any known or suspected, acute or chronic cause for their pulmonary symptoms other than asthma (e.g., COPD, chronic heart failure, etc.).

• Participant has a smoking habit (15 cigarettes per day) within a month prior to screening period, and/or has a smoking history (20 cigarettes per day) of more than 15 years.

• Participant has a disease of the cardiovascular, hepatic, renal, hematologic systems, or other severe disease.